NEWARK, DE / ACCESSWIRE / March 21, 2023 / The HIV/HBV/HCV test kits market size is projected to be valued at US$ 6,568.3 million in 2023 and is expected to rise to US$ 11,573.9 million by 2033. The ...

The HIV/HBV/HCV test kits market plays a vital role in the global fight against infectious diseases. These diagnostic tools are crucial for early detection and effective treatment of HIV, hepatitis B ...

HepatitisB paper Quest Diagnostics announced the availability of a new test to aid physicians in evaluating a patient's response to drug treatments for hepatitis B virus (HBV) infection. This first-of ...

Abbott announced that the FDA has approved its RealTime HBV assay for measuring the amount of hepatitis B virus (HBV) in human plasma or serum from individuals chronically infected with HBV. The ...

Quest Diagnostics Inc. DGX, a global provider of diagnostic information services, recently rolled out Hepatitis B Virus (HBV) Quantitative Test. This helps physicians evaluate a patient's response to ...

Before beginning direct-acting antiviral treatment for hepatitis C virus (HCV) infection, patients should be screened for hepatitis B virus (HBV) infection, according to an updated guideline from the ...

The increasing burden of HIV and viral hepatitis infections is estimated to boost the HIV/HBV/HCV test kits market. Assay-based test kits are expected to contribute a large market share as these are ...

September 2, 2010 — The US Food and Drug Administration (FDA) has approved for marketing the first fully automated hepatitis B virus (HBV) molecular assay (RealTime HBV on the m2000 system; Abbott ...

Assay can be used with the Abbott m2000 system to understand response to treatment. Abbott received approval from the FDA to market the Abbott RealTime HBV assay for quantitation of HBV in plasma or ...

An international research team has devised a simple $20 blood test that could be used widely in low-income and middle-income countries (LMICs) to help determine which patients with hepatitis B require ...